Correlation Between Crinetics Pharmaceuticals and Anebulo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Crinetics Pharmaceuticals and Anebulo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crinetics Pharmaceuticals and Anebulo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crinetics Pharmaceuticals and Anebulo Pharmaceuticals, you can compare the effects of market volatilities on Crinetics Pharmaceuticals and Anebulo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crinetics Pharmaceuticals with a short position of Anebulo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crinetics Pharmaceuticals and Anebulo Pharmaceuticals.
Diversification Opportunities for Crinetics Pharmaceuticals and Anebulo Pharmaceuticals
-0.41 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Crinetics and Anebulo is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Crinetics Pharmaceuticals and Anebulo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anebulo Pharmaceuticals and Crinetics Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crinetics Pharmaceuticals are associated (or correlated) with Anebulo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anebulo Pharmaceuticals has no effect on the direction of Crinetics Pharmaceuticals i.e., Crinetics Pharmaceuticals and Anebulo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Crinetics Pharmaceuticals and Anebulo Pharmaceuticals
Given the investment horizon of 90 days Crinetics Pharmaceuticals is expected to generate 0.4 times more return on investment than Anebulo Pharmaceuticals. However, Crinetics Pharmaceuticals is 2.5 times less risky than Anebulo Pharmaceuticals. It trades about 0.06 of its potential returns per unit of risk. Anebulo Pharmaceuticals is currently generating about -0.19 per unit of risk. If you would invest 5,626 in Crinetics Pharmaceuticals on August 30, 2024 and sell it today you would earn a total of 141.00 from holding Crinetics Pharmaceuticals or generate 2.51% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Crinetics Pharmaceuticals vs. Anebulo Pharmaceuticals
Performance |
| Timeline |
| Crinetics Pharmaceuticals |
| Anebulo Pharmaceuticals |
Crinetics Pharmaceuticals and Anebulo Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Crinetics Pharmaceuticals and Anebulo Pharmaceuticals
The main advantage of trading using opposite Crinetics Pharmaceuticals and Anebulo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crinetics Pharmaceuticals position performs unexpectedly, Anebulo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anebulo Pharmaceuticals will offset losses from the drop in Anebulo Pharmaceuticals' long position.| Crinetics Pharmaceuticals vs. Ikena Oncology | Crinetics Pharmaceuticals vs. Eliem Therapeutics | Crinetics Pharmaceuticals vs. HCW Biologics | Crinetics Pharmaceuticals vs. Tempest Therapeutics |
| Anebulo Pharmaceuticals vs. Ikena Oncology | Anebulo Pharmaceuticals vs. Eliem Therapeutics | Anebulo Pharmaceuticals vs. HCW Biologics | Anebulo Pharmaceuticals vs. Tempest Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |